sodium fluoride[18F]
Commercial- Indications
- Diagnostic imaging
Company intelligence / Profile preview
MITRO provides end-to-end CRO/CDMO services for radiolabeled drugs and molecular imaging agents. It has supported clinical approvals of radiopharmaceuticals globally. The company offers preclinical through clinical trial support—including drug screening, biodistribution studies, PK/PD evaluation—and registration application assistance. Notably involved in IND-enabling work such as [99mTc]SY101 for PSMA-positive prostate cancer which reached IND approval status in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MITRO Biotech Co., Ltd..